Corporate Governance
- Shionogi Global Health Access Policy Statement
- Ethical considerations in animal experiments
- Shionogi Group Quality Policy
- Business Partnership (Shionogi Group's Procurement Policy)
- Shionogi Group EHS Policy
- Efforts to Preserve the Environment
- Shionogi Group Risk Management Policy
- The Third Parties Expectations
- Shionogi Group Tax Policy
- Shionogi Disclosure Policy
- Clinical Trial Data Transparency Policy
- Shionogi Group Drug Safety Policy
- Protecting Intellectual Property
- Research Ethics Committee
- Clinical Trial Ethics Committee
- Shionogi AMR Position Paper
- Diversity and Inclusion
- Contributing through advances in science and healthcare
- People are key to Shionogi’s future and innovation
- Mother to Mother (SHIONOGI Project)
- Commitment to Fight COVID-19
- Socie (Shionogi Social Contribution Support Association)
- EHS Initiatives
- EHS Report
- Shionogi Health Declaration 2018
- Shionogi Group Smoke-Free Declaration
- Respect for Human Rights
- Desired Human Resources
- Remuneration and Evaluation System
- Human Resources Development
- Data